Before you sell to, join or invest in Macrotope, Inc.
MentionFox check on Macrotope, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/macrotope-inc-form-d-25000001
Check Macrotope, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Macrotope, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Macrotope, Inc. filed a Form D with the Securities and Exchange Commission on 2025-05-30.
Macrotope, Inc. filed a Form D notice of an exempt securities offering with the SEC on May 30, 2025. The filing reports $400K sold. Its industry group is Pharmaceuticals. It names Stephen Anderson (Executive Officer, Director), Elliot Camptbell (Executive Officer, Director) (SEC Form D, May 30, 2025).
Is this your company?
Sell to companies like Macrotope, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Macrotope, Inc.
Free to see. No signup.
More on the people and the money behind Macrotope, Inc., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Macrotope, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Macrotope, Inc. raises, hires or launches. No email unless you switch it on.
Watch Macrotope, Inc. →Get the full cited report on Macrotope, Inc.
What the filing shows about Macrotope, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Macrotope, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Macrotope, Inc.'s address as 158 Springdale Road, Princeton, NJ 08540.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Macrotope, Inc. is a registered filer with the SEC (CIK 1913044) and has filed since 2023-08-18. 2 filings are on record, the latest on 2025-05-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Macrotope, Inc.'s Form D of 2025-05-30 names Stephen Anderson and Elliot Camptbell as its officers, directors or promoters.
Its new offerings report $700K sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Macrotope
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Stephen Anderson is named as Executive Officer and Director on the Form D that Macrotope, Inc. filed with the SEC on 30 May 2025, one of 2 people that filing names.
Elliot Camptbell is named as Executive Officer and Director on the Form D that Macrotope, Inc. filed with the SEC on 30 May 2025, one of 2 people that filing names.
2 people named on the filing — 2 holding an executive role.
Named as of the 2025-05-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Macrotope, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Macrotope, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Macrotope, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Macrotope, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Macrotope, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-02 (macrotope.com).
Each opens in a new tab, filled in for Macrotope, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Northern New Jersey
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/macrotope-inc-form-d-25000001